Rationale for choosing a spacer at the first treatment stage for late deep periprosthetic knee joint infection

Q3 Medicine
S. Linnik, A. Afinogenova, G.E. finogenov, A. Spiridonova, Y. Tsololo, G. Karagezov, V.M. Khaidarov, D.V. Kravtsov, I. Kucheev, A. Khromov, I. Abbas, M.V. Maryshev
{"title":"Rationale for choosing a spacer at the first treatment stage for late deep periprosthetic knee joint infection","authors":"S. Linnik, A. Afinogenova, G.E. finogenov, A. Spiridonova, Y. Tsololo, G. Karagezov, V.M. Khaidarov, D.V. Kravtsov, I. Kucheev, A. Khromov, I. Abbas, M.V. Maryshev","doi":"10.18019/1028-4427-2023-29-2-173-179","DOIUrl":null,"url":null,"abstract":"Background Periprosthetic infection develops in 0.5 to 5.0 % of cases after knee replacement, which is a social and economic problem. The most common causes of periprosthetic infection are methicillin-resistant staphylococcus aureus (MRSA) (36 %), gram-negative bacteria, and microbial associations. The study was aimed at improving the results of the sanitizing stage of revision arthroplasty in patients with periprosthetic infection of the knee joint by a developed long-acting antimicrobial composition and improving the designs of articulating spacers of the knee joint. Materials and Methods The treatment results of 121 patients with knee joint periprosthetic infection were analyzed. Nine patients had an early periprosthetic infection and 112 had a late one. Patients in satisfactory condition with stable implant components who had early periprosthetic infection underwent surgical treatment of the purulent focuses, replacement of a polyethylene tibial insert, thorough surgical wound washing using pulse lavage, drainage, and VAC-therapy. Patients with late periprosthetic infection were divided into 3 groups on the basis of the spacer used. An articulating spacer based on the developed antimicrobial composition of prolonged action (RU 191236 patent) was used in 59 patients of the first group. Preformed spacers were implanted in 29 patients of the second group, and 18 patients of the third group got a block-shaped spacer. Results An antibacterial anti-adhesive non-toxic composition with a prolonged action based on bone cement with gentamicin and such antiseptics as poviargol, dioxydine, and high-molecular polyvinylpyrrolidone has been developed. All the patients underwent the sanitizing stage of revision arthroplasty, implant removal, and spacer installation. Periprosthetic infection recurrence developed in 3 patients of the first group, 9 patients of the second group and 7 patients of the third one. The average time from the sanitizing stage to the second final stage of revision was 3-6 (4.8 ± 1.9) months. Discussion According to scientific data, the impregnation of new antibiotics into bone cement with gentamicin does not improve the antimicrobial effect of a spacer, especially in case of antibiotic-resistant strains. Block-shaped and preformed spacers lead to infection recurrence and complications. Antiseptic impregnation with different mechanisms of action is able to affect antibiotic-resistant bacteria, and the polymer is able to prolong the effect. Conclusion The use of articulating spacers for the knee joint, which include an antimicrobial composition, allows preserving the function of the joint and reducing the number of infectious complications, which facilitates the final stage of revision arthroplasty.","PeriodicalId":37426,"journal":{"name":"Genij Ortopedii","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genij Ortopedii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18019/1028-4427-2023-29-2-173-179","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background Periprosthetic infection develops in 0.5 to 5.0 % of cases after knee replacement, which is a social and economic problem. The most common causes of periprosthetic infection are methicillin-resistant staphylococcus aureus (MRSA) (36 %), gram-negative bacteria, and microbial associations. The study was aimed at improving the results of the sanitizing stage of revision arthroplasty in patients with periprosthetic infection of the knee joint by a developed long-acting antimicrobial composition and improving the designs of articulating spacers of the knee joint. Materials and Methods The treatment results of 121 patients with knee joint periprosthetic infection were analyzed. Nine patients had an early periprosthetic infection and 112 had a late one. Patients in satisfactory condition with stable implant components who had early periprosthetic infection underwent surgical treatment of the purulent focuses, replacement of a polyethylene tibial insert, thorough surgical wound washing using pulse lavage, drainage, and VAC-therapy. Patients with late periprosthetic infection were divided into 3 groups on the basis of the spacer used. An articulating spacer based on the developed antimicrobial composition of prolonged action (RU 191236 patent) was used in 59 patients of the first group. Preformed spacers were implanted in 29 patients of the second group, and 18 patients of the third group got a block-shaped spacer. Results An antibacterial anti-adhesive non-toxic composition with a prolonged action based on bone cement with gentamicin and such antiseptics as poviargol, dioxydine, and high-molecular polyvinylpyrrolidone has been developed. All the patients underwent the sanitizing stage of revision arthroplasty, implant removal, and spacer installation. Periprosthetic infection recurrence developed in 3 patients of the first group, 9 patients of the second group and 7 patients of the third one. The average time from the sanitizing stage to the second final stage of revision was 3-6 (4.8 ± 1.9) months. Discussion According to scientific data, the impregnation of new antibiotics into bone cement with gentamicin does not improve the antimicrobial effect of a spacer, especially in case of antibiotic-resistant strains. Block-shaped and preformed spacers lead to infection recurrence and complications. Antiseptic impregnation with different mechanisms of action is able to affect antibiotic-resistant bacteria, and the polymer is able to prolong the effect. Conclusion The use of articulating spacers for the knee joint, which include an antimicrobial composition, allows preserving the function of the joint and reducing the number of infectious complications, which facilitates the final stage of revision arthroplasty.
在晚期深度假体周围膝关节感染的第一治疗阶段选择垫片的理由
背景:膝关节置换术后假体周围感染发生率为0.5% ~ 5.0%,是一个社会经济问题。假体周围感染最常见的原因是耐甲氧西林金黄色葡萄球菌(MRSA)(36%)、革兰氏阴性菌和微生物关联。该研究旨在通过开发长效抗菌组合物改善膝关节假体周围感染患者翻修关节置换术消毒阶段的结果,并改进膝关节关节间隔物的设计。材料与方法对121例膝关节假体周围感染患者的治疗结果进行分析。早期感染9例,晚期感染112例。早期假体周围感染的患者情况满意,植入物稳定,手术治疗化脓性病灶,置换聚乙烯胫骨插入物,用脉冲灌洗、引流彻底清洗手术伤口,并进行vaca治疗。晚期假体周围感染患者根据使用间隔器的不同分为3组。基于所开发的长效抗菌组合物(RU 191236专利)的关节间隔剂用于第一组59例患者。第二组29例植入预成型垫片,第三组18例植入块状垫片。结果在庆大霉素骨水泥的基础上,研制出了一种长效抗菌抗粘接无毒组合物,该组合物由聚维亚戈、二氧吡啶、高分子聚乙烯吡咯烷酮等防腐剂组成。所有患者均经历了翻修关节置换术、取出假体和安装垫片的消毒阶段。第一组3例假体周围感染复发,第二组9例,第三组7例。从消毒阶段到第二次翻修的平均时间为3-6(4.8±1.9)个月。科学数据表明,庆大霉素在骨水泥中浸渍新型抗生素并不能提高间隔剂的抗菌效果,特别是在耐药菌株的情况下。块状和预成型垫片导致感染复发和并发症。不同作用机制的抗菌剂浸渍都能对耐药菌产生影响,而聚合物能延长这种作用。结论膝关节使用含抗菌成分的关节垫片,可以保留关节功能,减少感染并发症的数量,有利于关节翻修成形术的最后阶段。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Genij Ortopedii
Genij Ortopedii Medicine-Surgery
CiteScore
0.70
自引率
0.00%
发文量
104
审稿时长
12 weeks
期刊介绍: Journal’s main goal is to contribute to the development of the contemporary medical science via presentation of fundamental and applied original scientific studies to the scientific and practical medical community that would widen and deepen the understanding of the most important problems in the field of traumatology, orthopaedics, and related specialties. Our journal provides a direct open access to its content which is based on the principle that the open access option promotes global exchange of knowledge and experience. Journal’s strategy: -Development of the journal as a scientific platform for researchers, doctors, post-graduates and residents -Attraction of highly-cited authors to publish their studies -Selection of manuscripts of scientific interest for readers that will impact on journal citation index in RINC -Increase in the portion of publications submitted by foreign authors and studies conducted in association with foreign scientists; growth of citations in the journals that are included into global systems of indexing and reputable databases -Improvement of the Journal’s web site in two languages for a greater accessibility by authors and readers -Introduction of the Journal into global indexing systems
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信